Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Strategic Education
STRA
$1.85B
| $2.27M | ﹤0.01% |
39,309
+16,786
| +75% | +$1.05M |
|
2302
Harmonic Inc
HLIT
$1.25B
| $2.27M | ﹤0.01% |
193,250
-349
| -0.2% | -$3.6K |
|
|
SAFE
2303
Safehold
SAFE
$1.16B
| $2.27M | ﹤0.01% |
18,059
+6,097
| +51% | +$743K |
|
2304
Alector
ALEC
$168M
| $2.27M | ﹤0.01% |
109,921
+36,526
| +50% | +$824K |
|
2305
Northwest Bancshares
NWBI
$2.3B
| $2.27M | ﹤0.01% |
160,236
+60,707
| +61% | +$845K |
|
|
SPR
2306
CALL
DELISTED
Spirit AeroSystems
SPR
| $2.27M | ﹤0.01% |
52,600
| – | – |
|
2307
HUTCHMED
HCM
$1.93B
| $2.27M | ﹤0.01% |
64,600
-609
| -0.9% | -$19.8K |
|
2308
PUT
Planet Fitness
PLNT
$4.42B
| $2.27M | ﹤0.01% |
25,000
| – | – |
|
2309
St. Joe Company
JOE
$3.54B
| $2.26M | ﹤0.01% |
43,486
+7,741
| +22% | +$375K |
|
2310
Supernus Pharmaceuticals
SUPN
$2.59B
| $2.26M | ﹤0.01% |
77,598
+15,098
| +24% | +$458K |
|
2311
CALL
Live Nation Entertainment
LYV
$40.6B
| $2.26M | ﹤0.01% |
+18,900
| New | +$2.04M |
|
2312
Washington Trust Bancorp
WASH
$743M
| $2.25M | ﹤0.01% |
39,995
+2,940
| +8% | +$163K |
|
2313
Jabil
JBL
$33B
| $2.25M | ﹤0.01% |
31,952
-40,460
| -56% | -$2.56M |
|
|
NBIS
2314
Nebius Group N.V.
NBIS
$48.3B
| $2.24M | ﹤0.01% |
37,093
-121,189
| -77% | -$8.93M |
|
|
EVRI
2315
DELISTED
Everi Holdings
EVRI
| $2.24M | ﹤0.01% |
104,825
+50,136
| +92% | +$1.14M |
|
|
ARGO
2316
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.24M | ﹤0.01% |
38,495
+20,405
| +113% | +$1.15M |
|
|
RTL
2317
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $2.23M | ﹤0.01% |
244,427
+18,961
| +8% | +$161K |
|
2318
Enova International
ENVA
$6.33B
| $2.22M | ﹤0.01% |
54,308
+6,972
| +15% | +$264K |
|
2319
Community Health Systems
CYH
$393M
| $2.22M | ﹤0.01% |
166,884
+61,022
| +58% | +$767K |
|
2320
PUT
Invesco Senior Loan ETF
BKLN
$6.97B
| $2.21M | ﹤0.01% |
+100,000
| New | +$2.21M |
|
|
LGF.B
2321
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.21M | ﹤0.01% |
143,378
-173,770
| -55% | -$2.43M |
|
2322
Surgery Partners
SGRY
$2.01B
| $2.2M | ﹤0.01% |
41,255
+26,916
| +188% | +$1.25M |
|
2323
Urban One Class D
UONEK
$22.8M
| $2.2M | ﹤0.01% |
65,000
-43
| -0.1% | -$2.1K |
|
2324
Regenxbio
RGNX
$620M
| $2.2M | ﹤0.01% |
67,373
-256
| -0.4% | -$8.72K |
|
|
GBT
2325
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.2M | ﹤0.01% |
75,188
-5,516
| -7% | -$171K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.